| Patents for C07C 59 - Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups oh, o-metal, cho, keto, ether, groups, groups, or groups (14,643) |
|---|
| 07/06/2004 | US6759547 Reduces serum glucose and serum triglyceride levels in diabetic mammals without the undesirable properties of reducing serum thyroxine levels and transiently raising triglyceride levels |
| 07/06/2004 | US6759546 Reducing serum glucose and serum triglyceride levels in diabetic mammals without the undesirable property of reducing serum thyroxine levels |
| 07/01/2004 | WO2004054957A2 Valproic acid analogues and pharmaceutical compositions thereof |
| 07/01/2004 | WO2004029008A3 Process for preparing fluorocarboxylic acids |
| 07/01/2004 | WO2002100341A3 Compounds for the treatment of metabolic disorders |
| 07/01/2004 | US20040127744 Catalytic depolymerization of polymers containing electrophilic linkages using nucleophilic reagents |
| 07/01/2004 | US20040127720 comprises heterocyclic carbenes; recycling polester/polyamide wastes; by-product inhibition |
| 07/01/2004 | US20040127495 Preferential suppressors of immunoglobulins, used as immunosuppressants and antiallergens |
| 07/01/2004 | CA2508855A1 Valproic acid analogues and pharmaceutical compositions thereof |
| 06/30/2004 | EP1242356B1 Perfluorinated acid fluorides and preparation thereof |
| 06/30/2004 | CN1509267A Thyroid hormone receptor atagonists for treating cardiac and metabolic disorders II |
| 06/30/2004 | CN1155599C Tricyclic triazolobenzazepine derivatives, process for producing same, and antiallergic agent |
| 06/30/2004 | CN1155554C Process for isolation of 2-keto-L-gulonic acid from fermented meat soup and use thereof |
| 06/24/2004 | WO2004052076A2 Mixed esters of dicarboxylic acids for use as pigment dispersants |
| 06/24/2004 | US20040122091 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
| 06/23/2004 | EP1431267A1 Carboxylic acid derivative compounds and drugs comprising these compounds as the active ingredient |
| 06/23/2004 | EP1201638B1 Photocurable composition containing iodonium salt compound |
| 06/23/2004 | CN1507431A Process for the remove of undesired flavour and odour components from potassium lactate |
| 06/22/2004 | US6753441 Condensing, in water and base, hydroxylated aromatic compound with glyoxylic acid using polycarboxylic acid catalyst |
| 06/17/2004 | US20040116740 Method for the purification of alpha-hydroxy acid on an industrial scale |
| 06/17/2004 | US20040116685 Method for solution phase synthesis of oligonucleotides |
| 06/17/2004 | US20040116408 therapeutic di- or tri-hydroxy derivatives of eicosapentaenoic acid or docosahexaenoic acid that diminish, prevent, or eliminate inflammation |
| 06/16/2004 | EP0977725B1 New fatty acid derivatives |
| 06/15/2004 | US6750360 Lipoxin compounds and their use in treating cell proliferative disorders |
| 06/15/2004 | US6750252 Tri-substituted phenyl derivatives and analogues |
| 06/10/2004 | WO2004048338A1 Noncyclic 1,3-dicarbonyl compounds as dual ppar agonists with potent antihyperglycemic and antihyperlipidemic activity |
| 06/10/2004 | WO2004048309A1 Vitamin d receptor modulators |
| 06/10/2004 | WO2004037776A3 Novel compounds and their use as prar-modulators |
| 06/10/2004 | US20040110966 2-methylenetetrahydro-2(5H)-furanone derivatives, their preparation from 4-oxovaleric acids, and homo-and copolymers of the furanones |
| 06/09/2004 | EP1426048A2 Treating hypertriglyceridemia with RXR agonists in combination with a PPARgamma agonist |
| 06/09/2004 | EP1425258A2 Hydroxyeicosenoic acid analogs |
| 06/09/2004 | EP1425256A1 Method for preparing unsaturated fatty hydroxy-acids and esters thereof, their use in pharmaceutical and/or cosmetic compositions |
| 06/09/2004 | DE3914067B4 Verfahren zur Reinigung von 2-Keto-L-gulonsäure A process for the purification of 2-keto-L-gulonic acid |
| 06/09/2004 | CN1503774A Carboxylic acid derivative and thereof |
| 06/08/2004 | US6747173 Method for the preparation of lactic acid and calcium sulphate dihydrate |
| 06/08/2004 | CA2152491C Preparation of polyoxyalkylene-alpha, omega-dicarboxylic acids |
| 06/02/2004 | EP1424321A1 Synthesis of optically active cyclohexylphenylglycolate esters |
| 06/02/2004 | EP1423362A1 New mandelic acid derivatives and their use as thrombin inhibitors |
| 06/02/2004 | EP1423119A1 Heterobicycles fkbp-ligands |
| 06/02/2004 | CN1501980A Degradation of epothilones and ethynyl substituted epothilones |
| 06/01/2004 | US6743784 Triarylethanes for treating symptoms, diseases and conditions in extra-reproductive tract tissues, such as osteopenia, that are responsive to treatment with estrogen |
| 05/27/2004 | US20040102634 For therapy and prophylaxis of hyperglycemia, hyperlipemia and inflammatory disease |
| 05/27/2004 | US20040102517 Novel1,2-diphenylethene derivatives for treatment of immune diseases |
| 05/27/2004 | US20040101523 Blocking biosynthesis of neurotransmitters; enzyme inhibitors; cardiovascular disorders |
| 05/27/2004 | DE19628519B4 Verfahren zur Herstellung von 1,4-Dioxan-2,5-dionen, Piperazoniumsalze von α-Hydroxycarbonsäuren und deren Verwendung A process for preparing 1,4-dioxane-2,5-diones, Piperazoniumsalze of α-hydroxycarboxylic acids and their use |
| 05/27/2004 | DE10348674A1 Racemisierung von optisch aktiven 2-substituierten Phenylglycinestern Racemization of optically active 2-substituted Phenylglycinestern |
| 05/26/2004 | EP1114023B1 Process for preparing carboxylic acids |
| 05/26/2004 | EP0915819B1 Illudin analogs useful as antitumor agents |
| 05/21/2004 | WO2004041266A1 Receptor function controlling agent |
| 05/21/2004 | WO2003037956A9 Crystalline polyglycolic acid, polyglycolic acid composition and processes for production of both |
| 05/21/2004 | CA2505322A1 Receptor function regulator |
| 05/20/2004 | US20040097755 Ionic liquids and their use as solvents |
| 05/20/2004 | US20040097753 Reacting unsaturated nitriles with hydrogen peroxide, to form heterocyclic amides, then hydrolysis and saponification to form acids and salts; chemical intermediates |
| 05/20/2004 | US20040097585 4-(2,6-difluorophenyl)-4-oxobutyric acid and derivatives; milder side effects; insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis, arteriosclerosis |
| 05/19/2004 | EP1419151A1 Chrystals including a malic acid salt of n-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3h-indole-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide, processes for its preparation and compositions thereof |
| 05/19/2004 | EP1419108A1 Method for the preparation of lactic acid and calcium sulphate dihydrate |
| 05/18/2004 | US6737417 Compounds with hydroxycarbonyl-halogenoalkyl side chain |
| 05/18/2004 | US6737068 Wipe formulation |
| 05/13/2004 | US20040092596 2-Aryloxy-2arylalkanoic acids for diabetes and lipid disorders |
| 05/13/2004 | US20040092594 Bicyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 05/13/2004 | US20040092560 Degradation of epothilones |
| 05/13/2004 | US20040092518 Compounds for the treatment of metabolic disorders |
| 05/13/2004 | US20040092516 Insulin resistance; antidiabetic agents; antilipemic agents; anticholesterol agents; cardiovascular disorders |
| 05/12/2004 | EP1418167A2 Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders |
| 05/12/2004 | EP1417287A1 Novel compositions containing acetoxylated fatty acids or fatty acid derivates, in particualr lubricant and pressure transmitting compositions, the preparation and use thereof |
| 05/12/2004 | EP1417169A2 Selective estrogen receptor modulators |
| 05/12/2004 | EP1237856B1 New tri-substituted phenyl derivatives and analogues |
| 05/12/2004 | EP1161410B1 Retinoid antagonists and use thereof |
| 05/12/2004 | EP1015441B1 Process to produce 4-hydroxy-2-oxo-pyrane derivatives useful as protease inhibitors |
| 05/06/2004 | WO2004037776A2 Novel compounds and their use as prar-modulators |
| 05/06/2004 | WO2004037760A2 Process for producing optically active 2-alkoxy-1-(trifluoromethyl-substituted phenyl)ethanol derivatives |
| 05/06/2004 | US20040086938 Site-specific isotopically-labeled proteins, amino acids, and biochemical precursors therefor |
| 05/06/2004 | EP1416032A1 Intumescent carbon-forming antipyren, method of production and use thereof |
| 05/06/2004 | EP1414809A1 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 05/06/2004 | EP1414778A1 Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc. |
| 05/06/2004 | EP1414384A2 Synthesis of epothilones and relates analogs |
| 05/06/2004 | EP1228027B1 3-heteroatom substituted and two carbon homologs of 15-hete and methods of use |
| 05/06/2004 | CA2503280A1 Allyloxy and allylsulfanyl compounds and use thereof as ppar modulators |
| 05/05/2004 | CN1494524A Process for stereo selective synthesis of prostacyclin derivatives |
| 05/05/2004 | CN1148343C Process for preparing carboxylic acids |
| 05/04/2004 | US6730798 Simultaneous halogenation and hydroxylation under lactonization, azidation, then amination to form 2(s),4(s),5(s),7(s)-2,7-dialkyl-4-hydroxy-5-amino-8-aryl-octanoyl amides |
| 04/29/2004 | WO2004035517A1 Specific markers of lipid peroxidation |
| 04/29/2004 | WO2003099810A3 Radiopharmaceuticals for imaging infection and inflammation |
| 04/29/2004 | WO2001095899A8 Pharmaceutical compositions comprising cannabidiol derivatives |
| 04/29/2004 | US20040082548 Cardiovascular disorders; Alzheimer's disease; anticholesterol agents |
| 04/28/2004 | EP1412317A1 Retinoid derivatives with antiangiogenic, antitumor and proapoptotic activities |
| 04/28/2004 | EP1411896A2 Surfactant compounds and uses thereof |
| 04/28/2004 | CN1492763A Compositions for delivering bisphosphonates |
| 04/27/2004 | US6727244 Mammalian metabolites of a tachykinin receptor antagonist |
| 04/27/2004 | CA2088562C The preparation of e-oxime ethers of phenylglyoxylic esters |
| 04/22/2004 | WO2004005243A3 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives |
| 04/22/2004 | US20040077900 Process for the preparation of a highly pure pharmaceutical intermediate, 4-(cyclopropylcarbonyl)-alpha, alpha-dimethylphenylacetic acid |
| 04/22/2004 | US20040077896 Compounds for the treatment of metabolic disorders |
| 04/21/2004 | EP1411041A1 Specific markers of lipid peroxidation |
| 04/21/2004 | EP1408986A2 Proteomimetic compounds and methods |
| 04/21/2004 | CN1491206A Malic acid addition salts of terbinafine |
| 04/21/2004 | CN1491200A Process for manufacture of phenylacetic acid derivatives |
| 04/21/2004 | CN1490297A Preparation of dextroilbuprofen |
| 04/21/2004 | CN1146534C (4S,5S)-and(4R, 5R)-gamma-methyl-delta-hydroxyl-alkanoic acid and its alkyl ester, preparation method and application |
| 04/20/2004 | US6723843 Oligosaccharide synthesis |